Oxapex 25 mg 100 Tablets Sixpex USA

Product Overview

Oxapex 25 mg 100 Tablets Sixpex USA delivers oxandrolone (C19H30O3), the synthetic DHT-derivative anabolic steroid exhibiting ~322-630 anabolic rating, at intermediate 25 mg potency bridging prescription (10 mg) and high-strength (50 mg) performance formats. Each sealed unit provides 100 tablets matching pharmaceutical bottling standards for institutional catalog integration.​

Sixpex USA’s domestic production emphasizes U.S. warehousing eliminating customs exposure while maintaining Schedule III-compliant specifications distinguishing legitimate product from underground conversions. This balanced dosage configuration serves specialist eCommerce platforms where advanced buyers require precise potency declaration and batch traceability essential for regulated workflows.

Oxapex positions within verified performance ecosystems targeting knowledgeable adult consumers familiar with Schedule III anabolics rather than pharmaceutical or recreational supplement categories, prioritizing commercial verification over general wellness claims.

Brand & Manufacturer Information

Sixpex USA manufactures U.S.-domesticated Schedule III anabolics including Oxapex through performance-grade facilities with domestic fulfillment serving institutional resellers requiring DEA-compliant traceability. Consistent 25 mg tablet morphology and “Oxapex 25” SKU enables catalog differentiation from 10 mg pharmaceutical and 50 mg institutional variants across portfolios.​

Domestic positioning supports encrypted platforms while published specifications confirm identity/potency distinguishing legitimate production from powder-converted alternatives prevalent in non-verified channels.

Active Compound Information

Oxapex contains oxandrolone (17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one), C2-oxa substituted DHT with high anabolic:androgenic dissociation (~10:1) and no aromatization pathway characteristic of 17α-alkylated steroids enabling oral bioavailability. Molecular weight 306.44; Schedule III classification reflects hepatotoxicity profile at performance dosing.​

25 mg strength represents 2.5-10× prescription Oxandrin while maintaining identical C17α-alkylation preventing first-pass metabolism. WADA S1 prohibited; regulated 21 CFR 1308.13. Listing identifies chemical specifications exclusively.

Product Specifications

• Product name: Oxapex 25 mg 100 Tablets Sixpex USA

• Brand/manufacturer: Sixpex USA​

• Active compound: Oxandrolone (C19H30O3)​

• Strength: 25 mg per tablet​

• Quantity per pack: 100 tablets

• Dosage form: Oral tablets

• Category: Schedule III anabolic steroid​

• Appearance: White scored tablets

• Primary packaging: Tamper-evident HDPE bottle​

• Label elements: 25 mg declaration, batch code​

Quality Control & Testing Standards

25 mg oxandrolone requires potency assay (90-110% claim), dissolution profiling, and stability testing bridging pharmaceutical and performance standards. Sixpex USA maintains batch documentation verifying C19H30O3 identity, uniform content, and Schedule III-compliant excipients.​

100-tablet pharmaceutical bottling prevents diversion; domestic warehousing maintains stability distinguishing from lower-count underground alternatives.

Intended Use & Market Positioning

Oxapex 25 mg serves CIII-authorized performance researchers managing intermediate-dosage anabolic inventories. 25 mg/100-tab configuration positions within balanced domestic catalogs. Zero protocols represented.

Packaging, Storage & Handling

Sealed HDPE bottles protect photo-sensitive oxandrolone; controlled 20-25°C locked storage per DEA. Facilities maintain lot-specific inventory logs.​

Purchasing & Availability Information

Domestic platforms provide encrypted CIII checkout, 21+ verification, discreet Priority fulfillment from Sixpex U.S. warehouses. 25 mg SKU differentiates institutional product.​

Legal & Regulatory Disclaimer

Oxandrolone constitutes DEA Schedule III; non-medical distribution/possession violates 21 USC §812. Buyer assumes Form 222 compliance; zero medical claims provided.​